Sweden's Aino Health Q2 net sales slip on project delays

Aino Health AB (publ)

03/08/2026 07:39

Overview
Sweden SaaS health platform's Q2 net sales declined yr/yr due to project start delays
Company posted a wider Q2 loss after financial items compared to last year
A public tender offer for all shares is ongoing, with acceptance period open until Aug 10, 2026

Outlook
Company says financial impact from new agreements will materialise gradually in late 2026 and 2027
Aino Health says international expansion pace depends on securing additional financing
Company says timing of implementations, churn and transaction costs remain key factors for coming qtrs

Result Drivers
PROJECT START DELAYS - Co said net sales were lower mainly due to delays in starting customer projects, affecting timing of revenue recognition
NEW CUSTOMER AGREEMENTS - Co signed new agreements representing about 5,500 subscriptions, but financial impact will materialise gradually as implementations are planned for later in 2026 and early 2027
COST CONTROL - Co said constrained cash position required strict cost control, limiting speed of growth investments

Company press release: ID:nMFN1PwlnX

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
 
SEK 6.70 mln
 

Reuters Recommended Reads
July 31 - Germany's PSI Software Q2 revenue rises 10.7% on order intake growth
July 31 - Sweden's Eurobattery Minerals Q2 loss narrows as project funding secured
Aug 3 - UK's Elixirr H1 revenue rises on AI demand

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)